OWC Pharmaceutical Research To Collaborate With Sourasky Medical Center In Tel Aviv For Safety Study On Its Cannabis-Based Tablets

Sourasky Medical Center Fund

ISRAEL: OWC Pharmaceutical Research Corp., the company transforming cannabis into scientifically proven and clinically approved medical solutions, announces an agreement with the Tel Aviv Sourasky Medical Center Fund. The medical center will perform a single-dose, randomized crossover study to compare the safety, tolerability, and pharmacokinetics of OWC’s tablet with Buccal Sativex in healthy adult volunteers. The Read the full article…